Jennifer Crombie, MD, Dana-Farber Cancer Institute, Boston, Massachusetts, discusses results from a real-world study of lisocabtagene maraleucel in patients with relapsed/refractory large B-cell lymphoma. Similar to published findings…
Tanya Siddiqi, MD, medical director of lymphoma, City of Hope, Orange County, California, discusses the primary analysis of the TRANSCEND CLL 004 trial. This phase 1/2, single-arm, multicenter…
Professor Peter Jennings, BPharm, PhD, DSc, at Kings College of London discussed the most promising treatments out there right now for combating Parkinson’s. He discussed the condition to…
According to Lars Brouwers, MD, MSc, a physician and PhD-candidate performing research on 3D-printing in the hospital environment, when doctors use traditional x-ray and 2DCT diagnostic tools in…
Hepatitis C is an RNA flavivirus that infects 4 million people in the United States, making it the leading indicator for liver transplant in the US. It has…
Scientists take aim at developing a single therapeutic intervention to achieve sustained clotting factor levels adequate enough to prevent bleeding in patient with hemophilia B without needing to…
Deutetrabenazine, a novel VMAT-2 inhibitor, was evaluated in phase 3 trials for the treatment of tardive dyskinesia. The deuterated form of tetrabenazine was found to be well-tolerated, safe,…
Millions of people worldwide suffer from Hepatitis C. Viekira Pak and Harvoni are both prescription drugs used to treat Hepatitis C. Harvoni is a combination of two drugs:…
Due to a shortage of psychiatrists in the healthcare service, doctors are trying new and innovative ways of providing their patients with the support they need. This can…
Those who are living with Parkinson’s disease or have a loved one who has PD will tell you how mentally and physically debilitating the illness can be. A…
Infection-related deaths from hepatitis C virus (HCV) have a high prevention rate if patients have access to direct-acting antiviral (DAA) treatments. Relaxing the eligibility criteria by widening the…
According to doctors, the non-compliance by patients towards their medication results in a loss of over $100 billion, which could be diverted to other areas of healthcare and…
